Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer10 Jan ETF JANT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Hold
7,917
﹤0.01% 3315
2026
Q1
$318K Buy
7,917
+2,677
+51% +$110K ﹤0.01% 3231
2025
Q4
$216K Hold
5,240
﹤0.01% 3513
2025
Q3
$208K Buy
+5,240
New +$203K ﹤0.01% 3456
2025
Q2
Sell
-8,472
Closed -$298K 3694
2025
Q1
$298K Buy
8,472
+1,674
+25% +$60.6K ﹤0.01% 2873
2024
Q4
$245K Hold
6,798
﹤0.01% 3009
2024
Q3
$239K Buy
6,798
+74
+1% +$2.55K ﹤0.01% 2998
2024
Q2
$229K Buy
6,724
+334
+5% +$11.1K ﹤0.01% 2924
2024
Q1
$211K Buy
+6,390
New +$204K ﹤0.01% 2984

Other funds holding JANT

Cambridge Investment Research Advisors's JANT Position: Q2 2026 in Review

Cambridge Investment Research Advisors held its AllianzIM U.S. Equity Buffer10 Jan ETF (JANT) position steady in Q2 2026 at 7,917 shares worth $348K. The position accounts for ﹤0.01% of the portfolio, ranked #3315.

Cambridge Investment Research Advisors first reported a position in JANT in Q1 2024 and has held it in 9 quarters since. 22 funds tracked by Wall St. Rank hold JANT as of Q2 2026.

  • Cambridge Investment Research Advisors held 7,917 shares of AllianzIM U.S. Equity Buffer10 Jan ETF worth $348K as of Q2 2026.
  • Cambridge Investment Research Advisors left its AllianzIM U.S. Equity Buffer10 Jan ETF share count unchanged in Q2 2026.
  • AllianzIM U.S. Equity Buffer10 Jan ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3315 holding.
  • Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer10 Jan ETF in Q1 2024 and has held it in 9 quarters since.
  • 22 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Jan ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.